Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thymus Neoplasms × Cisplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 203 Squamous Cell Carcinoma of Head and Neck 141 Head and Neck Neoplasms 121 Nasopharyngeal Carcinoma 99 Lung Neoplasms 97 Esophageal Neoplasms 97 Uterine Cervical Neoplasms 85 Stomach Neoplasms 78 Esophageal Squamous Cell Carcinoma 73 Breast Neoplasms 63 Urinary Bladder Neoplasms 57 Pancreatic Neoplasms 53 Small Cell Lung Carcinoma 52 Carcinoma, Squamous Cell 52 Neoplasms 50 Ovarian Neoplasms 41 Cholangiocarcinoma 41 Oropharyngeal Neoplasms 36 Neoplasm Metastasis 35 Biliary Tract Neoplasms 35 Adenocarcinoma Of Esophagus 32 Recurrence 26 Mesothelioma, Malignant 26 Gallbladder Neoplasms 24 Triple Negative Breast Neoplasms 21 Lymphoma 21 Laryngeal Neoplasms 19 Carcinoma, Transitional Cell 19 Sarcoma 18 Nasopharyngeal Neoplasms 18

Interventions

Drug Therapy 2 Blood Specimen Collection 2 ribociclib 1 pembrolizumab 1 palbociclib 1 epacadostat 1 bosutinib 1 amrubicin 1 Tumor Burden 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Quality of Life 1 Proton Therapy 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Immunotherapy 1 Histocompatibility Testing 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Everolimus 1 Erlotinib Hydrochloride 1 Cisplatin 1 Bevacizumab 1 177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01312324 2016-04-20

Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer

Samsung Medical Center

Phase 2 Completed

Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡